Degree | Department/Program | Institute | Year |
1992 | |||
1996 | |||
MSC | 2002 | ||
2004 | |||
2010 | |||
PROF.DR. | 2015 |
1. popgene, Supervisor: Dr. PROF.DR. ERSİ ABACI KALFOĞLU, İstanbul University, Graduate School of Natural and Applied Sciences, Forensics Department, istanbul, Turkey, .
1. Saç kıllarından kimlik belirtiminde fosfoglukomutaz-1 (PGM-1) enzimi polimorfizminden yararlanma, Supervisor: Dr. PROF.DR. A. SEDAT ÇÖLOĞLU, İstanbul University, Graduate School of Natural and Applied Sciences, Forensics Department, istanbul, Turkey, .
2. Bipolar, Supervisor: Dr. Prof.Dr.Ahmet Arslan, Gaziantep University, Graduate School of Health Sciences, Medical Biology Department, Gaziantep, Turkey, .
Title | Institute | Year |
PROF.DR. | UNIVERSITY OF MERSIN, MEDICAL FACULTY | 2015-08-26 - Continue |
2019
25. Aktas, S.; Un, I.; Omer Barlas, I.; Ozturk, A.; Ilkay Karagul, M. Evaluation of the Rho A/Rho-kinase pathway in the uterus of the rat model of polycystic ovary syndrome. ELSEVIER BV, 2019, 19, 45-54. 0 + 0http://dx.doi.org/10.1016/j.repbio.2019.01.005
2018
24. Ün, İ.; Barlas, İ.; Uyar, N.; Taşdelen, B.; Tiftik, N. Distribution of drug-metabolizing enzymes coding genes CYP2D6, CYP3A4, CYP3A5 alleles in a group of healthy Turkish population. WALTER DE GRUYTER GMBH, 2018, 44, 142-146. 800 + 0http://dx.doi.org/10.1515/tjb-2017-0226
2017
23. Batmaz, S.; Arikoglu, T.; Uyar, N.; Barlas, I.; Kuyucu, S. The Effect of Vitamin D Pathway Genes on Asthma Susceptibility, Asthma Control and Vitamin D Levels in Turkish Asthmatic Children. INT J HUM GENET, 2017, 17, 76-85. 600 + 510.1080/09723757.2017.1351128
Publications_012.pdf
Times Cited: 1
2016
22. Barlas, i.; Sezgin, O.; Dandara, C.; Türköz, G.; Yengel, E.; Cindi, Z.; Ankaralı, H.; Şardaş, S. Harnessing Knowledge on Very Important PharmacogenesCYP2C9andCYP2C19Variation for Precision Medicine in Resource-Limited Global Conflict . MARY ANN LIEBERT INC, 2016, 20, 604-609. 750 + 10http://dx.doi.org/10.1089/omi.2016.0133
Times Cited: 2
21. Saygılı, E.; Abou-Zeid, A.; Akkın, S.; Aklillu, E.; Barlas, i.; Borda-Rodriguez, A.; Boschele, F.; Çetin, Z.; Coşkun, E.; Coşkun, Y. An Open Letter in Support of Transformative Biotechnology and Social Innovation: SANKO University Innovation Summit in Medicine and Integrative Biology, Gaziantep, Turkey, May 5–7, 2016. MARY ANN LIEBERT INC, 2016, 20, 259-262. 125 + 0http://dx.doi.org/10.1089/omi.2016.0038
2015
20. Özdemir, V.; Dove, E.; Gürsoy, U.; Şardaş, S.; Yıldırım, A.; Yılmaz, Ş.; Barlas, i.; Güngör, K.; Mete, A.; Srivastava, S. Personalized medicine beyond genomics: alternative futures in big data—proteomics, environtome and the social proteome. J NEURAL TRANSM, 2015, 0-0. 100 + 29http://dx.doi.org/10.1007/s00702-015-1489-y
Publications_011.pdf
Times Cited: 4
19. Dove, E.; Barlas, i.; Birch, K.; Boehme, C.; Borda-Rodriguez, A.; Byne, W.; Chaverneff, F.; Coskun, Y.; Dahl, M.; Dereli, T. An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics". OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2015, 19, 435-442. 550 + 11https://dx.doi.org/10.1089/omi.2015.0075
Publications_003.PDF
Times Cited: 1
2014
18. Sezgin, O.; Barlas, i.; Ucbilek, E.; Yengel, E.; Altintas, E. Modified sequential Helicobacter Pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser turkish patients for CYP2C19 polymorphism is ineffective. ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77, 3-7. 800 + 8Publications_002.PDF
Times Cited: 1
2013
17. Yildir, S.; Sezgin, M.; Barlas, i.; Turkoz, G.; Ankarali, H.; Sahin, G.; Erdal, M. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis. RHEUMATOLOGY INTERNATIONAL, 2013, 33, 2637-2645. 600 + 13https://dx.doi.org/10.1007/s00296-013-2793-1
Times Cited: 2
16. Zamani, A.; Barlas, i.; Durakbasi-Dursun, G.; Ural, O.; Erdal, E.; Yildirim, M. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2013, 40, 482-487. 750 + 8https://dx.doi.org/10.1111/iji.12056
Times Cited: 1
15. Sezgin, M.; Barlas, i.; Yildir, S.; Turkoz, G.; Ankaralı, H.; Sahin, G.; Erdal, M. Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis. RHEUMATOLOGY INTERNATIONAL, 2013, 33, 2039-2043. 700 + 5https://dx.doi.org/10.1007/s00296-013-2688-1
Times Cited: 1
2012
14. Barlas, i.; Semiz, U.; Erdal, M.; Algul, A.; Ay, O.; Ates, M.; Camdeviren, H.; Basoglu, C.; Herken, H. Association between dopamine beta hydroxylase gene polymorphism and age at onset in male schizophrenia. ACTA NEUROPSYCHIATRICA, 2012, 24, 176-182. 700 + 5https://dx.doi.org/10.1111/j.1601-5215.2011.00617.x
Times Cited: 1
2010
13. şengül, c.; ERDAL, M.; aydın, n.; BALCI ŞENGÜl, c.; BARLAS, İ.; AYNACIOĞLU, A.; HERKEN, H. . ANATOLIAN JOURNAL OF PSYCHIATRY, 2010, 11, 18-22. 400 + 0
12. Sengul, C.; Erdal, M.; Aydin, N.; Sengul, C.; Barlas, i.; Aynacioglu, S.; Herken, H. The relation between IRS-1 Gly972Arg (insulin receptor substrate) gene polymorphism and olanzapine induced weight gain. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2010, 11, 18-22. 400 + 5Publications_010.pdf
Times Cited: 1
2009
11. Herken, H.; Erdal, M.; Aydin, N.; Sengul, C.; Karadag, F.; Barlas, i.; Akin, F. The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia. DNA AND CELL BIOLOGY, 2009, 28, 515-519. 300 + 5https://dx.doi.org/10.1089/dna.2009.0893
Times Cited: 1
10. Alasehirli, B.; Balat, A.; Barlas, i.; Kont, A. Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome. PEDIATRICS INTERNATIONAL, 2009, 51, 75-78. 750 + 0https://dx.doi.org/10.1111/j.1442-200X.2008.02655.x
9. Barlas, i.; Sezgin, M.; Erdal, M.; Sahin, G.; Ankarali, H.; Altintas, Z.; Tuerkmen, E. Association of (1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). RHEUMATOLOGY INTERNATIONAL, 2009, 29, 383-388. 800 + 13https://dx.doi.org/10.1007/s00296-008-0705-6
Times Cited: 2
8. Barlas, i.; Cetin, M.; Erdal, M.; Semiz, U.; Basoglu, C.; Ay, M.; Herken, H.; Uzun, O. Lack of Association Between DRD3 Gene Polymorphism and Response to Clozapine in Turkish Schizoprenia Patients. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B, 56-60. 750 + 14https://dx.doi.org/10.1002/ajmg.b.30770
Times Cited: 1
2008
7. Gursoy, S.; Erdal, E.; Sezgin, M.; Barlas, i.; Aydeniz, A.; Alasehirli, B.; Sahin, G. Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia?. RHEUMATOLOGY INTERNATIONAL, 2008, 28, 307-311. 500 + 5https://dx.doi.org/10.1007/s00296-007-0454-y
Times Cited: 1
6. Sezgin, M.; Barlas, i.; Ankarali, H.; Altintas, Z.; Turkmen, E.; Gokdogan, T.; Sahin, G.; Erdal, M. Tumour necrosis factor alpha-308G/A gene polymorphism: lack of association with knee osteoarthritis in a Turkish population. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26, 763-768. 650 + 8Publications_009.pdf
Times Cited: 1
2007
5. Sezgin, M.; Erdal, M.; Altintas, Z.; Ankarali, H.; Barlas, i.; Turkmen, E.; Sahin, G. Lack of association polymorphisms of the IL1RN, IL1A, and IL1B genes with knee osteoarthritis in Turkish patients. CLINICAL AND INVESTIGATIVE MEDICINE, 2007, 30, 86-92. 400 + 15Publications_002.pdf
Times Cited: 3
2003
4. Cataloluk, O.; Cakmak, E.; Buyukberber, N.; Barlas, i. Formalin fixing and paraffin embedding may lead to extra band development in PCR. NEW MICROBIOLOGICA, 2003, 26, 193-198. 650 + 45
Times Cited: 3
2002
3. Herken, H.; Erdal, M.; Aynacioglu, A.; Barlas, i.; Cataloluk, O.; Esgi, K.; Brockmoller, J.; Kaiser, R. Frequency of the 17-bp variable number of tandem repeat polymorphism in Turkish schizophrenic patients. SCHIZOPHRENIA RESEARCH, 2002, 58, 99-100. 225 + 5https://dx.doi.org/10.1016/S0920-9964(01)00391-7
Times Cited: 1
2001
2. Herken, H.; Erdal, E.; Mutlu, N.; Barlas, i.; Cataloluk, O.; Oz, F.; Guray, E. Possible association of temporomandibular joint pain and dysfunction with a polymorphism the serotonin transporter gene. AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2001, 120, 308-313. 500 + 8https://dx.doi.org/10.1067/mod.2001.115307
Times Cited: 1
1. Yilmaz, M.; Erdal, M.; Herken, H.; Cataloluk, O.; Barlas, i.; Bayazit, Y. Significance of serotonin transporter gene polymorphism in migraine. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 186, 27-30. 450 + 6https://dx.doi.org/10.1016/S0022-510X(01)00491-9
2013
5. Mert Altintas, Z.; Altintas, E.; Sezgin, O.; Gokdogan Edgunlu, T.; Ucbilek, E.; Nayir, E.; Barlas, i.; Erdal, M. The Effect of Genetic Variations of Methylene Tetrahydropholate Reductase Gene Polymorphisms on Ribavirin-Induced Anemia in Hepatitis C Patients. JOURNAL OF LIVER: DISEASE & TRANSPLANTATION, 2013, 2, 1-8. 32 + 010.4172/2325-9612.1000108
Publications_001.pdf
2011
4. Virit, O.; Erdal, M.; Savas, H.; Barlas, i.; Yumru, M.; Gokdogan, T.; Ozen, M.; Herken, H. Catechol-O-methyltransferase gene Val108/158Met polymorphism in bipolar disorder. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2011, 17, 46-50. 90 + 0https://dx.doi.org/10.1016/j.npbr.2011.02.002
3. Selek, s.; Kaya, m.; Erdal, M.; Bulut, M.; Ozen, M.; Yumru, M.; Barlas, i.; Kalenderoğlu, A.; Herken, H. Lack of Association Between COMT Gene Polymorphism and Treatment Outcome in Major Depression. JOURNAL OF MOOD DISORDERS, 2011, 1, 19-24. 20 + 3Publications_001.PDF
2003
2. Cataloluk, O.; Nacak, M.; Savas, H.; Tutkun, H.; Zoroglu, S.; Herken, H.; Barlas, i.; Ozen, M.; Arslan, A. Angiotensin converting enzyme gene polymorphism and its association to Bipolar Affective Disorder in Turkish patients. NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2003, 10, 129-132. 20 + 32
1. Cakmak, E.; Cataloluk, O.; Yoldas, T.; Arslan, A.; Herken, H.; Barlas, i.; Gorucu, S.; Yigiter, R. Migraine and angiotensin-converting enzyme association in Turkish patients. PAIN CLINIC, 2003, 15, 473-477. 50 + 19
2011
6. Türköz, G.; Barlas, i.; Ünal, S.; Antmen, A.; Kul, S. Childhood. MERSIN UNIV SAGLIK BILIM DERG, 2011, 4, 8-11. 160 + 0Publications_004.pdf
2010
5. Barlas, i.; Kalfoğlu, E.; Yükseloğlu, E.; Özcan, S.; Petridis, G. DNA-STR. TURKIYE KLINIKLERI J FOREN MED, 2010, 7, 28-32. 180 + 0Publications_003.pdf
2001
4. Erdal, M.; Neyal, M.; Yılmaz, M.; Barlas, I. Duchenne/Becker. CUKUROVA UNIVERSITESI TIP FAKULTESI DERGISI, 2001, 26, 157-161. 130 + 0Publications_006.pdf
3. Herken, H.; Erdal, M.; Esgi, K.; Barlas, I.; Erdal, N.; Aynacıoğlu, S. Schizophrenia. KLINIK PSIKOFARMAKOLOJI BULTENI, 2001, 11, 230-234. 110 + 0Publications_005.pdf
2000
2. Erdal, M.; Herken, H.; Barlas, I.; Erdal, N. Serotonin transporter gen polimorfizmi. KLINIK PSIKIYATRI, 2000, 3, 192-196. 150 + 0Publications_008.pdf
1. Erdal, M.; Erdal, N.; Barlas, I.; Görücü, S. Elektromanyetik alana maruz kalan kişilerde K-Ras onkogeninin moleküler analizi. MERSIN UNIVERSITESI TIP FAKULTESI DERGISI, 2000, 2, 107-112. 150 + 0Publications_007.pdf
1. Yılmaz, B.; Okuyaz, C.; Kömür, M.; Barlas, I.; Türköz, G., Association between childhood intractable epilepsy and interleukin 1 beta and interleukin 1 receptor antagonist gene polymorphisms. European Academy of Childhood Disability, 24th Annual Meeting, 2012-05-16, 2012-05-19, İstanbul, Turkey, 2012. 60
9. Alpaslan, N.; Ucbilek, E.; Barlas, I.; Sezgin, O.; Yaras, S., THE INVESTIGATION OF MIR-155, MIR-21, MIR-146A AND MIR-223 EXPRESSIONS IN HELICOBACTER PYLOR_I POSITIVE AND NEGATIVE INDIVIDUALS. 25th United European Gastroenterology Week Barcelona 2017, 2017-10-28, 2017-11-01, barselona, Spain, 2017. 35
8. Akgül , V.; Yeşil, T.; Ekinci, O.; Terzioğlu, B.; Omurtag, G.; Şardaş, S.; Barlas, I., The study on the frequency of xenobiotic-metabolizing enyzme gene polymorphisms CYP2C9 in an Turkish population. Fourth International Meeting on Pharmacy&Pharmaceutical Sciences, 2014-09-18, 2014-09-21, istanbul, Turkey, 2014. 10
7. Herken, H.; Erdal, M.; Sengül, C.; Aydın, N.; Karadağ, F.; Barlas, I.; Edgünlü, T., SNAP 25 polymorphisms and weight gain with olanzapine in schizophrenia patients. XVIth World Congress on Psychiatric Genetics, 2008-10-11, 2008-10-15, Osaka, Japan, 2008. 15
6. Altıntaş, Z.; Altıntaş, E.; Sezgin, O.; Gökdoğan, T.; Üçbilek, E.; Nayır, E.; Barlas, I., The effect of genetic defects of single carbon metabolism on ribavirin induced anemia in the patients with chronic hepatitis C. 18th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists, 2008-10-08, 2008-10-11, istanbul, Turkey, 2008. 8
5. Sengül, C.; Herken, H.; Erdal, M.; Aydın, N.; Barlas, I.; Aynacıoğlu, S.; Basdemir, M., The relation between insulin receptor substrate-1 gene and olanzapine-induced weight gain and smoking in schizophrenia patients. 20th ECNP Congress, 2007-10-13, 2007-10-17, vienna, Austria, 2007. 20
4. Herken, H.; Erdal, E.; Aydın, N.; Sengül, C.; Barlas, I.; Akın, S.; Aynacioglu, S., Possible impact of polymorphism of peroxizome proliferator activated receptor (PPAR) Pro12Ala genotype on olanzapine induced weight gain in schizophrenia patients. World Congress on Psychiatric Genetics XV, 2007-10-07, 2007-10-11, new york, United States of America, 2007. 20
3. Herken, H.; Erdal, M.; Cetin, M.; Barlas, I.; Basoğlu, C.; Uzun, O.; Selek, S., Association between 5-HT2A receptor gene T102C and 1438 G/A polymorphism and clozapine treatment response. XIV World Congress on Psychiatric Genetics, 2006-10-28, 2006-11-01, cagliari, Italy, 2006. 22
2. Balat, A.; Alaşehirli, B.; Barlas, I.; Güngör, M., Neuronal nitric oxide synthase gene polymorphism in children with primary nocturnal enuresis. 4th. International Congress of Uremic Research and Toxicity, 2005-09-14, 2005-09-17, izmir, Turkey, 2005. 37
1. Alaşehirli, B.; Balat, A.; Barlas, I.; Kont, A.; Sahinöz, S., Neuronal nitric oxide synthase gene polymorphism in children with minimal change nephrotic syndrome. 4th. International Congress of Uremic Research and Toxicity, 2005-09-14, 2005-09-17, izmir, Turkey, 2005. 35
1. Herken, H.; Erdal, M.; Aynacioğlu, A.; Barlas, I.; Esgi, K.; Çataloluk, O.; Brockmöller, j., Türk şizofreni hastalarında serotonin transporter gen polimorfizmi. 9. Anadolu Psikiyatri Günleri, 2000-06-13, 2000-06-17, edirne, Turkey, 2000. 25
23. AKTAŞ, S.; ÜN, İ.; BARLAS, İ.; BATU ÖZTÜRK, A.; KARAGÜL, M.; ÜNVAN, M., Polikistik Over Sendromu Oluşturulmuş Sıçanların Uteruslarında Rho A/Rho-kinaz Ekspresyonu ve Spontan Kontraksiyon Değişiklikleri. 14. Ulusal Histoloji ve Embriyoloji Kongresi, 2018-05-10, 2018-05-13, ANTALYA, Turkey, . 16
22. Batmaz, S.; Arıkoğlu, T.; Barlas, I.; Uyar, N.; Balcı, Ş.; Kuyucu, S., ’Kronik Astımlı Çocuklarda Klinik ve İmmunolojik Parametreler Üzerinde Serum D Vitamini Düzeyleri ve D Vitamini Gen Polimorfizmlerinin Rolünün Araştırılması. 21. Ulusal Allerji ve Klinik İmmunoloji Kongresi, 2014-10-25, 2014-10-29, Bodrum, Turkey, 2014. 16
21. Uyar, N.; Barlas, I.; Başterzi, A.; Özşin, E.; Erdal, M., İnozitol Monofosfataz 2 (IMPA2) Gen Polimorfizmlerinin İki Uçlu Bozukluk ile İlişkisinin Araştırılması. XIII.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2013-10-27, 2013-10-30, Aydın, Turkey, 2013. 20
20. Yıldır, S.; Sezgin, M.; Barlas, I.; Türköz, G.; Çamdeviren, H.; Günşah, Ş.; Erdal, M., Fas ve FasL gen polimorfizmleri Romatoid artrit ile ilişkili mi ?. Ankilozan - 5. Türk Romatoloji Kongresi , 2012-03-27, 2012-03-31, antalya, Turkey, 2012. 15
19. Sezgin, M.; Barlas, I.; Yıldır, S.; Türköz, G.; Çamdeviren, H.; Şahin, G.; Erdal, M., Diz osteoartritinde apoptizisle ilişkili Fas ve FasL gen polimorfizmleri etkili mi?. Ankilozan - 5. Türk Romatoloji Kongresi, 2012-03-27, 2012-03-31, antalya, Turkey, 2012. 17
18. Türköz, G.; Barlas, İ.; Ünal, S., Çocukluk çağı akut lenfoblastik lösemisi ile multi-drug resistance 1 (MDR1) geni ekspresyonu arasındaki ilişki. XI. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2009-10-28, 2009-10-31, Bodrum, Turkey, 2009. 25
17. Sengül, C.; Erdal, M.; Herken, H.; Aydın, N.; Karadağ, F.; Barlas, I.; Edgünlü, T., Şizofreni hastalarında olanzapine yanıtla sinaptozomla ilişkili protein (SNAP-25) gen polimorfizmi ilişkisi. 3. Ulusal Psikofarmakoloji Kongresi (3.UPFK), 2009-03-12, 2009-03-15, istanbul, Turkey, 2009. 7
16. Barlas, I.; Sezgin, M.; Erdal, M.; Şahin, G.; Ankaralı, H.; Altıntaş, Z.; Türkmen, E., Diz osteoartriti ile matriks metalloproteinaz 1-1607 1G/2G gen polimorfizmi ilişkili mi?. 21.Ulusal Fiziksel Tıp ve Rehabilitasyon Kongresi, 2007-10-24, 2007-10-29, Antalya, Turkey, 2007. 20
15. Erdoğan, N.; Akbaş, E.; Çolak, T.; Mutluhan, H.; Barlas, I., Manganez süperoksid dismutaz geninin Ala-9Val polimorfizmiyle meme kanseri riski arasındaki ilişkinin araştırılması. 9.Ulusal Meme Hastalıkları Kongresi, 2007-09-05, 2007-09-09, ankara, Turkey, 2007. 12
14. Sengül, C.; Herken, H.; Erdal, E.; Aydın, N.; Barlas, I.; Aynacıoğlu, Ş.; Başdemir, M., Şizofreni hastalarında sigara içimi ile IRS-1-(Insulin Receptor Substrate) geni polimorfizmi arası olası ilişki. Türkiye Psikiyatri Derneği, 11.yıllık Toplantı-Bahar Sempozyumu ve Avrupa’da Psikiyatri Uydu Sempozyumu, 2007-04-25, 2007-04-28, izmir, Turkey, 2007. 10
13. Altıntaş, Z.; Altıntaş, E.; Sezgin, O.; Gökdoğan, T.; Üçbilek, E.; Nayır, E.; Barlas, İ., Hepatit C’li hastalarda interferon ve ribavirin tedavisine bağlı anemide tek karbon metabolizmasındaki genetik kusurların etkisi. 23.Ulusal Gastroenteroloji Kongresi, 2006-11-04, 2006-11-07, istanbul, Turkey, 2006. 4
12. Sezgin, M.; Barlas, I.; Ankaralı, H.; Altıntaş, Z.; Türkmen, E.; Gökdoğan, T.; Şahin, G., TNF-alfa geninin -308 G/A polimorfizmi ile diz osteoartriti arasındaki ilişki. 2.Ulusal Romatizmal Hastalıklar Kongresi, 2006-04-26, 2006-04-30, antalya, Turkey, 2006. 16
11. Sezgin, M.; Erdal, M.; Altıntaş, Z.; Ankaralı, H.; Barlas, I.; Türkmen, E.; Şahin, G., IL-1alfa, IL-1beta ve IL-1Ra gen polimorfizmi diz osteoartriti ile ilişkili mi?. 2.Ulusal Romatizmal Hastalıklar Kongresi, 2006-04-26, 2006-04-30, antalya, Turkey, 2006. 10
10. Herken, H.; Erdal, M.; Çetin, M.; Barlas, I.; Basoğlu, C.; Uzun, Ö.; Gökdoğan, T., 5-HT2A reseptör geninin T102C ve 1438G/A polimorfizmleri ile klozapin tedavisine yanıt arası ilişki. 41. Ulusal Psikiyatri Kongresi, 2005-11-15, 2005-11-20, erzurum, Turkey, 2005. 12
9. İğci, Y.; Büyükberber, N.; Arslan, A.; Yıkılmaz, M.; Görücü, Ş.; Barlas, I.; Çakmak, E., p53 geni polimorfizminin çeşitli kanser tiplerinin olma sıklığı ile ilişkisinin araştırılması. 8.Ulusal Tıbbi Biyoloji Kongresi, 2003-10-14, 2003-10-17, adana, Turkey, 2003. 6
8. Barlas, I.; Savaş, H.; Arslan, A.; Herken, H.; Çataloluk, O.; Tutkun, H.; Özen, M., Türk populasyonunda ikiuçlu bozuklukta serotonin taşıyıcı protein gen polimorfizmi: Bir ön çalışma. 38. Ulusal Psikiyatri Kongresi, 2002-10-22, 2002-10-27, marmaris, Turkey, 2002. 18
7. Yılmaz, M.; Erdal, M.; Herken, H.; Çataloluk, O.; Barlas, I.; Bayazıt, Y., Significance of the serotonin transporter gene polymorphism in migraine. 3. Ulusal Biyolojik Psikiyatri Kongresi, 2001-06-18, 2001-06-20, kapadokya, Turkey, 2001. 11
6. Erdal, M.; Neyal, M.; Yılmaz, M.; Barlas, I., Duchenne/Becker kas distrofili hastalarda distrofin genindeki delesyonların polimeraz zincir reaksiyonu ile moleküler analizi. VI. Ulusal Tıbbi Biyoloji Kongresi (uluslararası katılımlı), 2000-11-02, 2000-11-05, denizli, Turkey, 2000. 16
5. Herken, H.; Erdal, M.; Mutlu, N.; Barlas, I.; Çataloluk, O.; Öz, F.; Güray, E., Myofasiyal ağrı sendromlu hastalarda serotonin transporter gen polimorfizmi. 36. Ulusal Psikiyatri Kongresi, 2000-10-03, 2000-10-07, antalya, Turkey, 2000. 12
4. Erdal, M.; Herken, H.; Barlas, İ.; Erdal, N., Serotonin transporter gen polimorfizmi. XII. Ulusal Biyofizik Kongresi, 2000-09-07, 2000-09-09, İstanbul, Turkey, 2000. 18
3. Erdal, M.; Barlas, İ., 46,XY fenotipik dişi bireyde SRY geninin PCR-SSCP yöntemiyle belirlenmesi. IV.Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, 2000-05-03, 2000-05-06, izmir, Turkey, 2000. 25
2. Erdal, M.; Erdal, N.; Barlas, I.; Görücü, Ş., Elektromanyetik alana maruz kalan kişilerde K-Ras onkogeninin moleküler analizi. XI. Ulusal Biyofizik Kongresi, 1999-10-31, 1999-11-02, antalya, Turkey, 1999. 18
1. Filoğlu, G.; Barlas, I.; Kalfoğlu, E.; Çöloğlu, A., Kan ve kıl kökünde fosfoglukomutaz-1 (PGM-1) enziminin İEF ile tiplendirilmesi. 8.Ulusal Adli Tıp Günleri, 1995-10-16, 1995-10-20, antalya, Turkey, 1995. 21
8. Acne vulgaris; is a dermatologic disorder (1, 2) with a complex etiolog, BAP, Project Number: 2018-2-TP2-2994, 13 TL, Manager, 2020,Completed. 100
7. The Investigation of miR-155, miR-21, miR-146a and miR-223 Expressions in Helicobacter pylori Positive and Negative Individuals, BAP, Project Number: 2016-1-TP3-1428, 24000 TL, Manager, 2019,Completed. 100
6. Endothelin Receptor A Gene Polymorphisms in Migren Patients, BAP, Project Number: 2015-TP2-1180, 7000 TL, Manager, 2016,Completed. 100
5. adam, BAP, Project Number: BAP-SBE TBB(NPÖ}2014-4 YL, 0 TL, Manager, 2015,Completed. 100
4. inositol, BAP, Project Number: BAP-SBE TTB (NU) 2011-3 YL, 0 TL, Manager, 2013,Completed. 100
3. childhood, BAP, Project Number: BAP-SBE TTB (GT) 2008-3 YL, 0 TL, Manager, 2009,Completed. 100
2. Matriks metalloproteinaz-1 (-1607 G -ins/del), matriks metalloproteinaz-2 (-1306C/T) ve matriks metalloproteinaz-9 (-1562 C/T) polimorfizmleri ile osteoartrit oluşum riski arasındaki ilişkinin araştırılması, BAP, Project Number: BAP-TF TTB (İÖB) 2006-1, 0 TL, Manager, 2007,Completed. 100
1. dna, BAP, Project Number: T-1160/18062001, 0 TL, Manager, 2004,Completed. 100
5. Investigation of Genetic Basis of Chronic Migraine-Related Sleep Disorders, BAP, Project Number: 2018-2-AP4-2932, 26 TL, Researcher, 2019,Completed. 50
4. RhoA/Rho-kinase Expressions and Uterine Contractility in a Rat Model of Polycystic Ovary Syndrome, TÜBİTAK, Project Number: 315S052, 56 TL, Researcher, 2017,Completed. 50
3. chronic, BAP, Project Number: BAP-TF DTB (SBTB) 2012-1 TU, 0 TL, Researcher, 2013,Completed. 50
2. resistant, BAP, Project Number: BAP TF DTB (BŞY) 2011-1 TU, 0 TL, Researcher, 2011,Completed. 50
1. presynaptic, BAP, Project Number: BAP-SBE TTB (TG) 2005-3 DR, 0 TL, Researcher, 2007,Completed. 50
5. Yıldız Yırtar, INVESTİGATION OF MİR-146A AND MIR-126 EXCHANGE RELATED TO REGULATION OF CXCL8 AND FOXP3 GENES IN ACNE PATIENTS, Graduate School of Health Sciences, Mersin University, Completed. 200
4. Kübra Akdeniz, The Investigation of Endothelin Receptor Gene A Polymorphism Association with Patients Diagnosed with Migraine, Graduate School of Health Sciences, Mersin University, Completed. 200
3. Neslihan Pınar Özateş, ADAM12, GDF5 ve TIMP4 Gen Polimorfizmlerinin Diz Osteoartriti ile İlişkisi, Graduate School of Health Sciences, Mersin University, Completed. 200
2. Gözde Türköz, Çocukluk çağı akut lenfoblastik lösemisi ile multidrug resistance 1 (MDR1) geni ekspresyonu arasındaki ilişki, Graduate School of Health Sciences, Mersin University, Completed. 200
1. Nisa Uyar, Inozitol monofosfataz-2 (IMPA2) gen polimorfizmlerinin bipolar bozukluk ile ilişkisinin araştırılması, Graduate School of Health Sciences, Mersin University, Completed. 200
1. Nisa UYAR, Helicobacter pylori, Graduate School of Health Sciences, Mersin University, Completed. 400
1. MERSIN UNIVERSITESI TIP FAKULTESI DERGISI , PUBLICATION BOARD MEMBER, E-ISSN : 1302 - 6682, 2011-01-04 - 2013-12-30. 125
1. GENETICS AND MOLECULAR RESEARCH , [ 2014 : 1 ] . 4
2. OMICS , [ 2016 : 1 ] . 5
1. MUGLA SITKI KOCMAN UNIVERSITESI DOCENTLIK ATAMA DOSYASI DEGERLENDIRME , [ 2015 : 1 ] . 0
2. TUBITAK DIS DEGERLENDIRME , [ 2015 : 1 ] . 0
3. TUBITAK DIS DEGERLENDIRME , [ 2013 : 2 ] . 2
4. TUBITAK DIS DEGERLENDIRME , [ 2014 : 1 ] . 1
5. TUBITAK DIS DEGERLENDIRME , [ 2015 : 2 ] . 2
6. BEZMI ALEM SAGLIK BILIMLERI DERGISI , [ 2016 : 1 ] . 1
7. MERSIN UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI , [ 2016 : 2 ] . 2
1. , 2000-10-07, antalya, Turkey. 25
2. , 2002-10-27, Marmaris, Turkey. 25
3. , 2005-09-17, izmir, Turkey. 25
4. , 2005-11-15, Erzurum, Turkey. 25
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Fall | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 526 | General Medical Biology | Institute of Health Sciences | Medical Biology | 2-2-3 |
Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Spring | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | SEM DR | Seminar II | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Fall | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Fall | BİO 517 | Hereditary Metabolic Disorders | Institute of Health Sciences | Medical Biology | 2-2-3 |
Fall | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 508 | Molecular Genetics I | Institute of Health Sciences | Medical Biology | 2-2-3 |
Spring | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 616 | Cellular Control and Signal Transduction | Institute of Health Sciences | Medical Biology | 3-0-3 |
Spring | BİO 510 | Molecular Biology of Cancer | Institute of Health Sciences | Medical Biology | 2-0-2 |
Fall | BİO 613 | Pharmacogenetics | Institute of Health Sciences | Medical Biology | 2-0-2 |
Fall | BİO 510 | Molecular Biology of Cancer | Institute of Health Sciences | Medical Biology | 2-0-2 |
Fall | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 608 | Concepts In Molecular Genetics | Institute of Health Sciences | Medical Biology | 2-0-2 |
Spring | BİO 525 | Molecular Genetics of Forensic Medicine | Institute of Health Sciences | Medical Biology | 2-2-3 |
Fall | BİO 603 | Cancer Genetics | Institute of Health Sciences | Medical Biology | 2-0-2 |
Fall | BİO 510 | Molecular Biology of Cancer | Institute of Health Sciences | Medical Biology | 2-0-2 |
Fall | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 517 | Hereditary Metabolic Disorders | Institute of Health Sciences | Medical Biology | 2-2-3 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 608 | Concepts In Molecular Genetics | Institute of Health Sciences | Medical Biology | 2-0-2 |
Spring | BİO 802 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | SEM YL | Seminar | Institute of Health Sciences | Institute of Health Sciences | 0-0-0 |
Spring | BİO 526 | General Medical Biology | Institute of Health Sciences | Medical Biology | 2-2-3 |
Fall | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Fall | BİO 510 | Molecular Biology of Cancer | Institute of Health Sciences | Medical Biology | 2-0-2 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 801 | Specialty Area | Institute of Health Sciences | Department of Medical Biology | 4-0-4 |
Spring | BİO 603 | Cancer Genetics | Institute of Health Sciences | Medical Biology | 2-0-2 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 517 | Hereditary Metabolic Disorders | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-2-3 |
Spring | BİO 621 | Molecular Immunology | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-0-2 |
Fall | BİO 618 | Advanced Molecular Molecular Genetics | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 3-0-3 |
Fall | BİO 509 | Molecular Genetics II | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-2-3 |
Fall | BİO 620 | Introduction To Medical Genetics | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 3-0-3 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | BİO 510 | Molecular Biology of Cancer | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-0-2 |
Spring | BİO 508 | Molecular Genetics I | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-2-3 |
Spring | BİO 603 | Cancer Genetics | Graduate School of Health Scie... | MEDİCAL BİOLOGY | 2-0-2 |
Term | C.Code | Course | Faculty/College/Institute | Department/Program | T-A-C |
Spring | TBI110 | Genetic | College of Icel Health | Midwifery | 2-0-2 |